Hello,
Welcome to Insider Healthcare. I'm Lydia Ramsey Pflanzer, and today in healthcare news:
- 3 ways Dollar General could upend the healthcare industry, according to experts;
- One chart shows the most common COVID-19 symptoms based on your vaccination status;
- Experts say there's no evidence the Lambda variant is worse than Delta.
If you're new to this newsletter, sign up here. Comments, tips? Email me at [email protected] or tweet @lydiaramsey125. Let's get to it…

Jeremy Hogan/SOPA Images/LightRocket via Getty Images

Dollar General hired a key health executive, but that's just the start. Here are 3 ways the discount chain could upend the $3.8 trillion healthcare industry.
- Dollar General is a low-cost retailer with 17,000 stores, mainly in rural communities.
- In July, it hired former McKinsey consultant Dr. Albert Wu to be its first chief medical officer.
- Analysts and experts laid out three strategies the chain could pursue in healthcare delivery.

Joanna Lin Su/Insider
The 5 most common COVID-19 symptoms based on your vaccination status, in one chart

- COVID-19 symptoms look somewhat different for vaccinated people who get breakthrough cases and unvaccinated people, a study found.
- Unvaccinated people are more likely to report a fever and persistent cough.
- They're also more likely to get severely sick and reported more symptoms in total.

Public Health England
The Lambda variant is dominating Peru, but experts say there's no evidence it's worse than Delta
- The Lambda variant is one of the latest to raise concern in the public health community.
- A preprint study suggested the variant's mutation could help it evade antibodies and spread quickly.
- One researcher said it's not perfectly clear yet: Lambda cases are decreasing in some places, while increasing in others.
Here's what you need to know>>
More stories we're reading:
- Half of Americans are now fully vaccinated against COVID-19 (Insider)
- Inside Flare Capital's Bill Geary life as he invested in health-tech during a pandemic from Nantucket (Bloomberg)
- Novavax delayed its timeline again to submit its COVID-19 vaccine for US authorization, raising further doubts about its domestic launch (Insider)
- JPMorgan's Morgan Health invested in primary-care startup Vera Whole Health (CNBC)
- Lydia
Read the original article on Business Insider